Description
Description
Matrixyl 3000-Type Peptide Powder is a trade-reference blend based on the well-known combination of Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7. The system is used in advanced anti-aging formulations to provide complementary matrikine-type signaling within a low-dose peptide architecture.
Chemical & Technical Profile
| INCI / Identity | Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 type peptide blend |
|---|---|
| CAS No. | Mixture; no single CAS |
| Molecular Formula | Peptide blend |
| Molecular Weight | Not applicable |
| Physical Form | White to off-white powder |
| Solubility | Water-compatible after appropriate dispersion/solubilization |
| Functional Category | Palmitoylated matrikine peptide blend |
Mechanism of Action / Technical Function
Palmitoyl Tripeptide-1 is associated with extracellular-matrix renewal signaling, while Palmitoyl Tetrapeptide-7 is used in peptide systems targeting age-related matrix and inflammatory signaling. The palmitoyl groups increase lipophilic character and help the peptides associate with skin-lipid and interfacial environments. The blend should therefore be viewed as a coordinated signal-peptide system rather than as a bulk protein ingredient.
Formulation Guidelines
Prepare a controlled aqueous or carrier premix and add during cool-down. Avoid prolonged heating, extreme pH, strong oxidants, proteases, and unnecessary high shear. Amphiphilic palmitoylated peptides can interact with surfactant micelles and emulsifier interfaces, so confirm uniform incorporation in the actual base. Do not calculate dosage by assuming equivalence with a branded liquid Matrixyl 3000 preparation; this powder is a type/reference grade and should be formulated according to its own active composition.
Compatibility & Stability
Monitor pH, clarity or dispersion quality, odor, precipitation, and emulsion stability. In multi-peptide systems, verify preservative compatibility and control total solids to prevent tack or haze.
R&D, Scale-Up & Quality Control
R&D qualification of Matrixyl 3000-Type Peptide Powder should include peptide-blend identity, dispersion quality, pH, and haze. For manufacturing scale-up, define and control Matrixyl 3000-Type premix preparation, cool-down addition, and contact with surfactant-rich interfaces rather than transferring only the ingredient percentages. The batch is technically acceptable when the palmitoylated peptide blend remains uniformly incorporated without precipitation or tack-related instability.
Packaging, Shipping & Storage
Supplied in a sealed aluminum pouch. Store tightly closed, cool, dry, and protected from light and humidity. Refrigeration is preferred for long-term peptide stability.
Applications
Anti-aging serums, eye products, firming creams, emulsions, gel-creams, and advanced multi-peptide systems.
Reviews
There are no reviews yet.